Sim&Cure develops the medical software Sim&Size® to optimize the choice of endovascular devices for the treatment of cerebral aneurysm.
Sim&Cure is the first company to be cleared to market a patient-based simulation model for aneurysm treatment that allows prediction of the deployment of medical devices (flow diverter, intrasaccular device, laser-cuter stent). Sim&Size® simulates each size and type of device according to the patient’s unique anatomy in order to provide essential information prior to the choice of sizing.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 23, 2019 | Series A | €3M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
IT Translation | — | Series A |